English
简体中文
Total: £ 56.28
Published Date: 2026-04-24 | Pages: 120 | Tables: 118 | Pharma & Healthcare
The global Cloprostenol Sodium Injection market was valued at US$ 232 million in 2025 and is anticipated to reach US$ 307 million by 2032, at a CAGR of 4.0% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Cloprostenol Sodium Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Cloprostenol Sodium Injection is a veterinary hormonal preparation containing cloprostenol sodium, a prostaglandin F2α analogue. It induces luteolysis and regulates the reproductive cycle in animals, and is commonly used in cattle, swine, and horses for estrus synchronization, breeding management, parturition induction, and treatment of uterine disorders.
In 2025, the global production of Cloprostenol Sodium Injection reached 14.7 million units, with an average selling price of USD 15.8 per unit. Total production capacity was approximately 20 million units, and the industry gross margin was around 30%–40%. The cost structure consists of about 80% direct materials, 15% manufacturing overhead, and 5% labor. The industrial chain includes upstream suppliers of cloprostenol sodium API, excipients, glass vials, and stoppers, while downstream comprises farms, veterinary hospitals, and related end users.
The North American market for Cloprostenol Sodium Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Cloprostenol Sodium Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Cloprostenol Sodium Injection include Elanco, MSD, Biogénesis Bagó, Boehringer Ingelheim, VetPharma, Interchemie, Ningbo Second Hormone Factory, Ningbo Sansheng Biotechnology, Ginten Biotechnology, Ningbo CREATOR ANIMAL Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Cloprostenol Sodium Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cloprostenol Sodium Injection. The Cloprostenol Sodium Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cloprostenol Sodium Injection market comprehensively. Regional market sizes by Type, by Application, by Specification, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cloprostenol Sodium Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Elanco
MSD
Biogénesis Bagó
Boehringer Ingelheim
VetPharma
Interchemie
Ningbo Second Hormone Factory
Ningbo Sansheng Biotechnology
Ginten Biotechnology
Ningbo CREATOR ANIMAL Pharmaceutical
TIEN (Tianjin) Pharmaceutical Co., Ltd.
Qilu Animal Health Products
Hefei Xinkexin Animal Pharmaceutical
Jiangxi Bolai Pharmacy
Segment by Type
20ml/vial
100ml/vial
Others
Segment by Specification
250 µg/mL
100 µg/mL
by Application
Cows
Ewes
Sows
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Specification, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Cloprostenol Sodium Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Cloprostenol Sodium Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Cloprostenol Sodium Injection Market Overview
1.1 Product Definition
1.2 Cloprostenol Sodium Injection by Type
1.2.1 Global Cloprostenol Sodium Injection Market Value by Type: 2025 vs 2032
1.2.2 20ml/vial
1.2.3 100ml/vial
1.2.4 Others
1.3 Cloprostenol Sodium Injection by Specification
1.3.1 Global Cloprostenol Sodium Injection Market Value by Specification: 2025 vs 2032
1.3.2 250 µg/mL
1.3.3 100 µg/mL
1.4 Cloprostenol Sodium Injection by Application
1.4.1 Global Cloprostenol Sodium Injection Market Value by Application: 2025 vs 2032
1.4.2 Cows
1.4.3 Ewes
1.4.4 Sows
1.4.5 Others
1.5 Global Cloprostenol Sodium Injection Market Size Estimates and Forecasts
1.5.1 Global Cloprostenol Sodium Injection Revenue 2021–2032
1.5.2 Global Cloprostenol Sodium Injection Sales 2021–2032
1.5.3 Global Cloprostenol Sodium Injection Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 Cloprostenol Sodium Injection Market Competition by Manufacturers
2.1 Global Cloprostenol Sodium Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Cloprostenol Sodium Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Cloprostenol Sodium Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Cloprostenol Sodium Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Cloprostenol Sodium Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Cloprostenol Sodium Injection, Product Types and Applications
2.7 Global Key Manufacturers of Cloprostenol Sodium Injection, Date of Entry into the Industry
2.8 Global Cloprostenol Sodium Injection Market Competitive Situation and Trends
2.8.1 Global Cloprostenol Sodium Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Cloprostenol Sodium Injection Players Market Share by Revenue
2.8.3 Global Cloprostenol Sodium Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cloprostenol Sodium Injection Market Scenario by Region
3.1 Global Cloprostenol Sodium Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Cloprostenol Sodium Injection Sales by Region: 2021–2032
3.2.1 Global Cloprostenol Sodium Injection Sales by Region: 2021–2026
3.2.2 Global Cloprostenol Sodium Injection Sales by Region: 2027–2032
3.3 Global Cloprostenol Sodium Injection Revenue by Region: 2021–2032
3.3.1 Global Cloprostenol Sodium Injection Revenue by Region: 2021–2026
3.3.2 Global Cloprostenol Sodium Injection Revenue by Region: 2027–2032
3.4 North America Cloprostenol Sodium Injection Market Facts & Figures by Country
3.4.1 North America Cloprostenol Sodium Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Cloprostenol Sodium Injection Sales by Country (2021–2032)
3.4.3 North America Cloprostenol Sodium Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cloprostenol Sodium Injection Market Facts & Figures by Country
3.5.1 Europe Cloprostenol Sodium Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Cloprostenol Sodium Injection Sales by Country (2021–2032)
3.5.3 Europe Cloprostenol Sodium Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cloprostenol Sodium Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Cloprostenol Sodium Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Cloprostenol Sodium Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Cloprostenol Sodium Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cloprostenol Sodium Injection Market Facts & Figures by Country
3.7.1 Latin America Cloprostenol Sodium Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Cloprostenol Sodium Injection Sales by Country (2021–2032)
3.7.3 Latin America Cloprostenol Sodium Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Cloprostenol Sodium Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Cloprostenol Sodium Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Cloprostenol Sodium Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Cloprostenol Sodium Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cloprostenol Sodium Injection Sales by Type (2021–2032)
4.1.1 Global Cloprostenol Sodium Injection Sales by Type (2021–2026)
4.1.2 Global Cloprostenol Sodium Injection Sales by Type (2027–2032)
4.1.3 Global Cloprostenol Sodium Injection Sales Market Share by Type (2021–2032)
4.2 Global Cloprostenol Sodium Injection Revenue by Type (2021–2032)
4.2.1 Global Cloprostenol Sodium Injection Revenue by Type (2021–2026)
4.2.2 Global Cloprostenol Sodium Injection Revenue by Type (2027–2032)
4.2.3 Global Cloprostenol Sodium Injection Revenue Market Share by Type (2021–2032)
4.3 Global Cloprostenol Sodium Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Cloprostenol Sodium Injection Sales by Application (2021–2032)
5.1.1 Global Cloprostenol Sodium Injection Sales by Application (2021–2026)
5.1.2 Global Cloprostenol Sodium Injection Sales by Application (2027–2032)
5.1.3 Global Cloprostenol Sodium Injection Sales Market Share by Application (2021–2032)
5.2 Global Cloprostenol Sodium Injection Revenue by Application (2021–2032)
5.2.1 Global Cloprostenol Sodium Injection Revenue by Application (2021–2026)
5.2.2 Global Cloprostenol Sodium Injection Revenue by Application (2027–2032)
5.2.3 Global Cloprostenol Sodium Injection Revenue Market Share by Application (2021–2032)
5.3 Global Cloprostenol Sodium Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Elanco
6.1.1 Elanco Company Information
6.1.2 Elanco Description and Business Overview
6.1.3 Elanco Cloprostenol Sodium Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Elanco Cloprostenol Sodium Injection Product Portfolio
6.1.5 Elanco Recent Developments/Updates
6.2 MSD
6.2.1 MSD Company Information
6.2.2 MSD Description and Business Overview
6.2.3 MSD Cloprostenol Sodium Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 MSD Cloprostenol Sodium Injection Product Portfolio
6.2.5 MSD Recent Developments/Updates
6.3 Biogénesis Bagó
6.3.1 Biogénesis Bagó Company Information
6.3.2 Biogénesis Bagó Description and Business Overview
6.3.3 Biogénesis Bagó Cloprostenol Sodium Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Biogénesis Bagó Cloprostenol Sodium Injection Product Portfolio
6.3.5 Biogénesis Bagó Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Company Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Cloprostenol Sodium Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Boehringer Ingelheim Cloprostenol Sodium Injection Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 VetPharma
6.5.1 VetPharma Company Information
6.5.2 VetPharma Description and Business Overview
6.5.3 VetPharma Cloprostenol Sodium Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 VetPharma Cloprostenol Sodium Injection Product Portfolio
6.5.5 VetPharma Recent Developments/Updates
6.6 Interchemie
6.6.1 Interchemie Company Information
6.6.2 Interchemie Description and Business Overview
6.6.3 Interchemie Cloprostenol Sodium Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Interchemie Cloprostenol Sodium Injection Product Portfolio
6.6.5 Interchemie Recent Developments/Updates
6.7 Ningbo Second Hormone Factory
6.7.1 Ningbo Second Hormone Factory Company Information
6.7.2 Ningbo Second Hormone Factory Description and Business Overview
6.7.3 Ningbo Second Hormone Factory Cloprostenol Sodium Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Ningbo Second Hormone Factory Cloprostenol Sodium Injection Product Portfolio
6.7.5 Ningbo Second Hormone Factory Recent Developments/Updates
6.8 Ningbo Sansheng Biotechnology
6.8.1 Ningbo Sansheng Biotechnology Company Information
6.8.2 Ningbo Sansheng Biotechnology Description and Business Overview
6.8.3 Ningbo Sansheng Biotechnology Cloprostenol Sodium Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Ningbo Sansheng Biotechnology Cloprostenol Sodium Injection Product Portfolio
6.8.5 Ningbo Sansheng Biotechnology Recent Developments/Updates
6.9 Ginten Biotechnology
6.9.1 Ginten Biotechnology Company Information
6.9.2 Ginten Biotechnology Description and Business Overview
6.9.3 Ginten Biotechnology Cloprostenol Sodium Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Ginten Biotechnology Cloprostenol Sodium Injection Product Portfolio
6.9.5 Ginten Biotechnology Recent Developments/Updates
6.10 Ningbo CREATOR ANIMAL Pharmaceutical
6.10.1 Ningbo CREATOR ANIMAL Pharmaceutical Company Information
6.10.2 Ningbo CREATOR ANIMAL Pharmaceutical Description and Business Overview
6.10.3 Ningbo CREATOR ANIMAL Pharmaceutical Cloprostenol Sodium Injection Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Ningbo CREATOR ANIMAL Pharmaceutical Cloprostenol Sodium Injection Product Portfolio
6.10.5 Ningbo CREATOR ANIMAL Pharmaceutical Recent Developments/Updates
6.11 TIEN (Tianjin) Pharmaceutical Co., Ltd.
6.11.1 TIEN (Tianjin) Pharmaceutical Co., Ltd. Company Information
6.11.2 TIEN (Tianjin) Pharmaceutical Co., Ltd. Description and Business Overview
6.11.3 TIEN (Tianjin) Pharmaceutical Co., Ltd. Cloprostenol Sodium Injection Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 TIEN (Tianjin) Pharmaceutical Co., Ltd. Cloprostenol Sodium Injection Product Portfolio
6.11.5 TIEN (Tianjin) Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Qilu Animal Health Products
6.12.1 Qilu Animal Health Products Company Information
6.12.2 Qilu Animal Health Products Description and Business Overview
6.12.3 Qilu Animal Health Products Cloprostenol Sodium Injection Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Qilu Animal Health Products Cloprostenol Sodium Injection Product Portfolio
6.12.5 Qilu Animal Health Products Recent Developments/Updates
6.13 Hefei Xinkexin Animal Pharmaceutical
6.13.1 Hefei Xinkexin Animal Pharmaceutical Company Information
6.13.2 Hefei Xinkexin Animal Pharmaceutical Description and Business Overview
6.13.3 Hefei Xinkexin Animal Pharmaceutical Cloprostenol Sodium Injection Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Hefei Xinkexin Animal Pharmaceutical Cloprostenol Sodium Injection Product Portfolio
6.13.5 Hefei Xinkexin Animal Pharmaceutical Recent Developments/Updates
6.14 Jiangxi Bolai Pharmacy
6.14.1 Jiangxi Bolai Pharmacy Company Information
6.14.2 Jiangxi Bolai Pharmacy Description and Business Overview
6.14.3 Jiangxi Bolai Pharmacy Cloprostenol Sodium Injection Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Jiangxi Bolai Pharmacy Cloprostenol Sodium Injection Product Portfolio
6.14.5 Jiangxi Bolai Pharmacy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cloprostenol Sodium Injection Industry Chain Analysis
7.2 Cloprostenol Sodium Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cloprostenol Sodium Injection Production Mode & Process Analysis
7.4 Cloprostenol Sodium Injection Sales and Marketing
7.4.1 Cloprostenol Sodium Injection Sales Channels
7.4.2 Cloprostenol Sodium Injection Distributors
7.5 Cloprostenol Sodium Injection Customer Analysis
8 Cloprostenol Sodium Injection Market Dynamics
8.1 Cloprostenol Sodium Injection Industry Trends
8.2 Cloprostenol Sodium Injection Market Drivers
8.3 Cloprostenol Sodium Injection Market Challenges
8.4 Cloprostenol Sodium Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Cloprostenol Sodium Injection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Cloprostenol Sodium Injection Market Value by Specification (US$ Million), 2025 vs 2032
Table 3. Global Cloprostenol Sodium Injection Market Value by Application (US$ Million), 2025 vs 2032
Table 4. Global Cloprostenol Sodium Injection Market Competitive Situation by Manufacturers in 2025
Table 5. Global Cloprostenol Sodium Injection Sales (K Units) of Key Manufacturers (2021–2026)
Table 6. Global Cloprostenol Sodium Injection Sales Market Share by Manufacturers (2021–2026)
Table 7. Global Cloprostenol Sodium Injection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 8. Global Cloprostenol Sodium Injection Revenue Share by Manufacturers (2021–2026)
Table 9. Global Market Cloprostenol Sodium Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 10. Global Key Players of Cloprostenol Sodium Injection, Industry Ranking, 2023 vs 2024 vs 2025
Table 11. Global Key Manufacturers of Cloprostenol Sodium Injection, Manufacturing Sites and Headquarters
Table 12. Global Key Manufacturers of Cloprostenol Sodium Injection, Product Types and Applications
Table 13. Global Key Manufacturers of Cloprostenol Sodium Injection, Date of Entry into the Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Cloprostenol Sodium Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cloprostenol Sodium Injection Revenue, 2025
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global Cloprostenol Sodium Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 18. Global Cloprostenol Sodium Injection Sales by Region (K Units), 2021–2026
Table 19. Global Cloprostenol Sodium Injection Sales Market Share by Region (2021–2026)
Table 20. Global Cloprostenol Sodium Injection Sales by Region (K Units), 2027–2032
Table 21. Global Cloprostenol Sodium Injection Sales Market Share by Region (2027–2032)
Table 22. Global Cloprostenol Sodium Injection Revenue by Region (US$ Million), 2021–2026
Table 23. Global Cloprostenol Sodium Injection Revenue Market Share by Region (2021–2026)
Table 24. Global Cloprostenol Sodium Injection Revenue by Region (US$ Million), 2027–2032
Table 25. Global Cloprostenol Sodium Injection Revenue Market Share by Region (2027–2032)
Table 26. North America Cloprostenol Sodium Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 27. North America Cloprostenol Sodium Injection Sales by Country (K Units), 2021–2026
Table 28. North America Cloprostenol Sodium Injection Sales by Country (K Units), 2027–2032
Table 29. North America Cloprostenol Sodium Injection Revenue by Country (US$ Million), 2021–2026
Table 30. North America Cloprostenol Sodium Injection Revenue by Country (US$ Million), 2027–2032
Table 31. Europe Cloprostenol Sodium Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 32. Europe Cloprostenol Sodium Injection Sales by Country (K Units), 2021–2026
Table 33. Europe Cloprostenol Sodium Injection Sales by Country (K Units), 2027–2032
Table 34. Europe Cloprostenol Sodium Injection Revenue by Country (US$ Million), 2021–2026
Table 35. Europe Cloprostenol Sodium Injection Revenue by Country (US$ Million), 2027–2032
Table 36. Asia Pacific Cloprostenol Sodium Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 37. Asia Pacific Cloprostenol Sodium Injection Sales by Region (K Units), 2021–2026
Table 38. Asia Pacific Cloprostenol Sodium Injection Sales by Region (K Units), 2027–2032
Table 39. Asia Pacific Cloprostenol Sodium Injection Revenue by Region (US$ Million), 2021–2026
Table 40. Asia Pacific Cloprostenol Sodium Injection Revenue by Region (US$ Million), 2027–2032
Table 41. Latin America Cloprostenol Sodium Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 42. Latin America Cloprostenol Sodium Injection Sales by Country (K Units), 2021–2026
Table 43. Latin America Cloprostenol Sodium Injection Sales by Country (K Units), 2027–2032
Table 44. Latin America Cloprostenol Sodium Injection Revenue by Country (US$ Million), 2021–2026
Table 45. Latin America Cloprostenol Sodium Injection Revenue by Country (US$ Million), 2027–2032
Table 46. Middle East and Africa Cloprostenol Sodium Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 47. Middle East and Africa Cloprostenol Sodium Injection Sales by Country (K Units), 2021–2026
Table 48. Middle East and Africa Cloprostenol Sodium Injection Sales by Country (K Units), 2027–2032
Table 49. Middle East and Africa Cloprostenol Sodium Injection Revenue by Country (US$ Million), 2021–2026
Table 50. Middle East and Africa Cloprostenol Sodium Injection Revenue by Country (US$ Million), 2027–2032
Table 51. Global Cloprostenol Sodium Injection Sales (K Units) by Type (2021–2026)
Table 52. Global Cloprostenol Sodium Injection Sales (K Units) by Type (2027–2032)
Table 53. Global Cloprostenol Sodium Injection Sales Market Share by Type (2021–2026)
Table 54. Global Cloprostenol Sodium Injection Sales Market Share by Type (2027–2032)
Table 55. Global Cloprostenol Sodium Injection Revenue (US$ Million) by Type (2021–2026)
Table 56. Global Cloprostenol Sodium Injection Revenue (US$ Million) by Type (2027–2032)
Table 57. Global Cloprostenol Sodium Injection Revenue Market Share by Type (2021–2026)
Table 58. Global Cloprostenol Sodium Injection Revenue Market Share by Type (2027–2032)
Table 59. Global Cloprostenol Sodium Injection Price (US$/Unit) by Type (2021–2026)
Table 60. Global Cloprostenol Sodium Injection Price (US$/Unit) by Type (2027–2032)
Table 61. Global Cloprostenol Sodium Injection Sales (K Units) by Application (2021–2026)
Table 62. Global Cloprostenol Sodium Injection Sales (K Units) by Application (2027–2032)
Table 63. Global Cloprostenol Sodium Injection Sales Market Share by Application (2021–2026)
Table 64. Global Cloprostenol Sodium Injection Sales Market Share by Application (2027–2032)
Table 65. Global Cloprostenol Sodium Injection Revenue (US$ Million) by Application (2021–2026)
Table 66. Global Cloprostenol Sodium Injection Revenue (US$ Million) by Application (2027–2032)
Table 67. Global Cloprostenol Sodium Injection Revenue Market Share by Application (2021–2026)
Table 68. Global Cloprostenol Sodium Injection Revenue Market Share by Application (2027–2032)
Table 69. Global Cloprostenol Sodium Injection Price (US$/Unit) by Application (2021–2026)
Table 70. Global Cloprostenol Sodium Injection Price (US$/Unit) by Application (2027–2032)
Table 71. Elanco Company Information
Table 72. Elanco Description and Business Overview
Table 73. Elanco Cloprostenol Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 74. Elanco Cloprostenol Sodium Injection Product
Table 75. Elanco Recent Developments/Updates
Table 76. MSD Company Information
Table 77. MSD Description and Business Overview
Table 78. MSD Cloprostenol Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 79. MSD Cloprostenol Sodium Injection Product
Table 80. MSD Recent Developments/Updates
Table 81. Biogénesis Bagó Company Information
Table 82. Biogénesis Bagó Description and Business Overview
Table 83. Biogénesis Bagó Cloprostenol Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 84. Biogénesis Bagó Cloprostenol Sodium Injection Product
Table 85. Biogénesis Bagó Recent Developments/Updates
Table 86. Boehringer Ingelheim Company Information
Table 87. Boehringer Ingelheim Description and Business Overview
Table 88. Boehringer Ingelheim Cloprostenol Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 89. Boehringer Ingelheim Cloprostenol Sodium Injection Product
Table 90. Boehringer Ingelheim Recent Developments/Updates
Table 91. VetPharma Company Information
Table 92. VetPharma Description and Business Overview
Table 93. VetPharma Cloprostenol Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 94. VetPharma Cloprostenol Sodium Injection Product
Table 95. VetPharma Recent Developments/Updates
Table 96. Interchemie Company Information
Table 97. Interchemie Description and Business Overview
Table 98. Interchemie Cloprostenol Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 99. Interchemie Cloprostenol Sodium Injection Product
Table 100. Interchemie Recent Developments/Updates
Table 101. Ningbo Second Hormone Factory Company Information
Table 102. Ningbo Second Hormone Factory Description and Business Overview
Table 103. Ningbo Second Hormone Factory Cloprostenol Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 104. Ningbo Second Hormone Factory Cloprostenol Sodium Injection Product
Table 105. Ningbo Second Hormone Factory Recent Developments/Updates
Table 106. Ningbo Sansheng Biotechnology Company Information
Table 107. Ningbo Sansheng Biotechnology Description and Business Overview
Table 108. Ningbo Sansheng Biotechnology Cloprostenol Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 109. Ningbo Sansheng Biotechnology Cloprostenol Sodium Injection Product
Table 110. Ningbo Sansheng Biotechnology Recent Developments/Updates
Table 111. Ginten Biotechnology Company Information
Table 112. Ginten Biotechnology Description and Business Overview
Table 113. Ginten Biotechnology Cloprostenol Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 114. Ginten Biotechnology Cloprostenol Sodium Injection Product
Table 115. Ginten Biotechnology Recent Developments/Updates
Table 116. Ningbo CREATOR ANIMAL Pharmaceutical Company Information
Table 117. Ningbo CREATOR ANIMAL Pharmaceutical Description and Business Overview
Table 118. Ningbo CREATOR ANIMAL Pharmaceutical Cloprostenol Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 119. Ningbo CREATOR ANIMAL Pharmaceutical Cloprostenol Sodium Injection Product
Table 120. Ningbo CREATOR ANIMAL Pharmaceutical Recent Developments/Updates
Table 121. TIEN (Tianjin) Pharmaceutical Co., Ltd. Company Information
Table 122. TIEN (Tianjin) Pharmaceutical Co., Ltd. Description and Business Overview
Table 123. TIEN (Tianjin) Pharmaceutical Co., Ltd. Cloprostenol Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 124. TIEN (Tianjin) Pharmaceutical Co., Ltd. Cloprostenol Sodium Injection Product
Table 125. TIEN (Tianjin) Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 126. Qilu Animal Health Products Company Information
Table 127. Qilu Animal Health Products Description and Business Overview
Table 128. Qilu Animal Health Products Cloprostenol Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 129. Qilu Animal Health Products Cloprostenol Sodium Injection Product
Table 130. Qilu Animal Health Products Recent Developments/Updates
Table 131. Hefei Xinkexin Animal Pharmaceutical Company Information
Table 132. Hefei Xinkexin Animal Pharmaceutical Description and Business Overview
Table 133. Hefei Xinkexin Animal Pharmaceutical Cloprostenol Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 134. Hefei Xinkexin Animal Pharmaceutical Cloprostenol Sodium Injection Product
Table 135. Hefei Xinkexin Animal Pharmaceutical Recent Developments/Updates
Table 136. Jiangxi Bolai Pharmacy Company Information
Table 137. Jiangxi Bolai Pharmacy Description and Business Overview
Table 138. Jiangxi Bolai Pharmacy Cloprostenol Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 139. Jiangxi Bolai Pharmacy Cloprostenol Sodium Injection Product
Table 140. Jiangxi Bolai Pharmacy Recent Developments/Updates
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Cloprostenol Sodium Injection Distributors List
Table 144. Cloprostenol Sodium Injection Customers List
Table 145. Cloprostenol Sodium Injection Market Trends
Table 146. Cloprostenol Sodium Injection Market Drivers
Table 147. Cloprostenol Sodium Injection Market Challenges
Table 148. Cloprostenol Sodium Injection Market Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
Table 152. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cloprostenol Sodium Injection
Figure 2. Global Cloprostenol Sodium Injection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Cloprostenol Sodium Injection Market Share by Type: 2025 & 2032
Figure 4. 20ml/vial Product Picture
Figure 5. 100ml/vial Product Picture
Figure 6. Others Product Picture
Figure 7. Global Cloprostenol Sodium Injection Market Value by Specification (US$ Million), 2021–2032
Figure 8. Global Cloprostenol Sodium Injection Market Share by Specification: 2025 vs 2032
Figure 9. 250 µg/mL Product Picture
Figure 10. 100 µg/mL Product Picture
Figure 11. Global Cloprostenol Sodium Injection Market Value by Application (US$ Million), 2021–2032
Figure 12. Global Cloprostenol Sodium Injection Market Share by Application: 2025 & 2032
Figure 13. Cows
Figure 14. Ewes
Figure 15. Sows
Figure 16. Others
Figure 17. Global Cloprostenol Sodium Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Cloprostenol Sodium Injection Market Size (US$ Million), 2021–2032
Figure 19. Global Cloprostenol Sodium Injection Sales (K Units), 2021–2032
Figure 20. Global Cloprostenol Sodium Injection Average Price (US$/Unit), 2021–2032
Figure 21. Cloprostenol Sodium Injection Report Years Considered
Figure 22. Cloprostenol Sodium Injection Sales Share by Manufacturers in 2025
Figure 23. Global Cloprostenol Sodium Injection Revenue Share by Manufacturers in 2025
Figure 24. Top 5 and Top 10 Global Cloprostenol Sodium Injection Players: Market Share by Revenue in Cloprostenol Sodium Injection in 2025
Figure 25. Cloprostenol Sodium Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 26. Global Cloprostenol Sodium Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 27. North America Cloprostenol Sodium Injection Sales Market Share by Country (2021–2032)
Figure 28. North America Cloprostenol Sodium Injection Revenue Market Share by Country (2021–2032)
Figure 29. United States Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Canada Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Europe Cloprostenol Sodium Injection Sales Market Share by Country (2021–2032)
Figure 32. Europe Cloprostenol Sodium Injection Revenue Market Share by Country (2021–2032)
Figure 33. Germany Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. France Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. U.K. Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Italy Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Russia Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Asia Pacific Cloprostenol Sodium Injection Sales Market Share by Region (2021–2032)
Figure 39. Asia Pacific Cloprostenol Sodium Injection Revenue Market Share by Region (2021–2032)
Figure 40. China Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Japan Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. South Korea Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. India Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Australia Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. China Taiwan Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Southeast Asia Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Latin America Cloprostenol Sodium Injection Sales Market Share by Country (2021–2032)
Figure 48. Latin America Cloprostenol Sodium Injection Revenue Market Share by Country (2021–2032)
Figure 49. Mexico Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Brazil Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Argentina Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Colombia Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Middle East and Africa Cloprostenol Sodium Injection Sales Market Share by Country (2021–2032)
Figure 54. Middle East and Africa Cloprostenol Sodium Injection Revenue Market Share by Country (2021–2032)
Figure 55. Turkey Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Saudi Arabia Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. UAE Cloprostenol Sodium Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Global Sales Market Share of Cloprostenol Sodium Injection by Type (2021–2032)
Figure 59. Global Revenue Market Share of Cloprostenol Sodium Injection by Type (2021–2032)
Figure 60. Global Cloprostenol Sodium Injection Price (US$/Unit) by Type (2021–2032)
Figure 61. Global Sales Market Share of Cloprostenol Sodium Injection by Application (2021–2032)
Figure 62. Global Revenue Market Share of Cloprostenol Sodium Injection by Application (2021–2032)
Figure 63. Global Cloprostenol Sodium Injection Price (US$/Unit) by Application (2021–2032)
Figure 64. Cloprostenol Sodium Injection Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
